CVXL-0107

N/A

Report date: 2022/07/04 19:38:02
NME

Base Information

Drug NameCVXL-0107
Drug Alias NameCVXL-0107
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionGlutamate release inhibitors
TargetsNot applicable
Therapy Area/IndicationsParkinson Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryFrance
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesDomain Therapeutics SA
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesClevexel Pharma
Active IndicationsN/A
Inactive IndicationsParkinson Disease

Other Information

ATC CodeN/A
Related LinksN/A